PROTEIN POLYMER TECHNOLOGIES SHOWCASES
NEW PRODUCTS AT SOCIETY OF INTERVENTIONAL RADIOLOGY 31st
ANNUAL MEETING
SAN DIEGO, February 28 -- Protein Polymer
Technologies, Inc. (OTC Bulletin Board: PPTI.OB), today
announced that in partnership with Surgica Corporation, they will be exhibiting
at the Society of Interventional Radiology 31st Annual Scientific Meeting
being held March 30 – April 4, 2006 in Toronto, Canada.
The companies plan to showcase three new convenience
kits which are packaged with Surgica’s proprietary
foam embolization products – PVA Plus™, MicroStat™ and
MaxiStat™. These new convenience kits were designed
to offer improved ease of use and overall procedure efficiency
for physicians.
Highlights of the new convenience kits include:
•
PVA Plus™ and spherical MicroStat™ foam embolization
particles pre-packaged dry in sterile syringes.
•
MaxiStat™ particles, offering the advantages of
a larger-sized spherical PVA foam embolization particle
as an alternative to small coils for up to medium-sized
vessels, packaged individually, dry in a vial.
•
All components required to prepare the particles for
delivery. The particles can be hydrated directly in the
physician’s preferred injection fluid.
The convenience kits take advantage of the rapid hydration
properties of PVA Plus™, MicroStat™ and MaxiStat™.
For further information visit Surgica’s exhibit
booth, #1431, in the Technical Exhibit Hall.
The SIR Annual Scientific Meeting brings together more
than 4,000 members and industry representatives from
across the globe, and provides advances in research,
new devices, world-renowned presenters and training fundamentals
to create the most comprehensive meeting for medical
professionals in the nonsurgical field of interventional
radiology.
To schedule media interviews or
request product images, please contact Bryan deCastro
or Carole Boucard.
Contacts
Investor Contact:
Erin Davis
Director of Communications and Investor Relations
Protein Polymer Technologies, Inc.
(858) 558-6064 x 120
edavis@ppti.com |
Media Contact:
Bryan deCastro, (631) 495-9177
Carole Boucard, (954) 370-2524
Creative Public Relations
|
About
Protein Polymer Technologies
Protein Polymer Technologies, Inc. is a biotechnology company that discovers
and develops innovative therapeutic devices to improve medical and surgical
outcomes. The Company focuses on developing technology and products to be used
for soft tissue augmentation, tissue adhesives and sealants, wound healing
support and drug delivery devices. Protein Polymer Technologies’ proprietary
protein-based biomaterials are uniquely tailored to optimize clinical performance
and contain no human or animal components that could potentially transmit or
cause disease. The Company is headquartered in San Diego, California. For additional
information about the Company, please visit www.ppti.com.
To date, PPTI has been issued twenty-six U.S. patents on its core technology
with corresponding issued and pending patents in key international markets.
Safe Harbor
This press release contains forward-looking
statements that are based on management’s views
and expectations. Actual results could differ materially
from those expressed here; further, the Company is
not obligated to comment specifically on those differences.
Risks associated with the Company’s activities
include raising adequate capital to continue operations,
scientific and product development uncertainties,
competitive products and approaches, continuing collaborative
partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up. The reader
is encouraged to refer to the Company’s 2004
Annual Report Form 10-KSB, and 10KSB/A and other
recent filings with the Securities and Exchange Commission,
copies of
which are available from the Company, to further ascertain
the risks associated with the above statements.
